content: <PAGE>
  
  
                  UNITED STATES SECURITIES AND EXCHANGE COMMISSION
  
                                Washington, DC 20549
  
                                  ----------------
  
                                      FORM 8-K
                                   CURRENT REPORT
  
             Pursuant to Section 13 or 15(d) of the Securities Exchange
                             Act of 1934 Date of Report
  
                (Date of earliest event reported): December 3, 2001
  
                          Commission File Number: 000-28460
  
                          FUSION MEDICAL TECHNOLOGIES, INC.
               (Exact name of registrant as specified in its charter)
  
                Delaware                                        94-3177221
                --------                                        ----------
  (State of incorporation or organization)                (IRS Employer I.D. No.)
  
                              34715 Ardenwood Boulevard
                              -------------------------
                                  Fremont, CA 94555
                                  -----------------
                      (Address of principal executive offices)
  
                                   (510) 818-4600
                                   --------------
                (Registrant's telephone number, including area code)
  
  
  <PAGE>
  
  Item 5. Other Events
  
       On September 13, 2001, we received notice from Sulzer Spine-Tech Inc. that
  they had filed a Demand for Arbitration with the American Arbitration
  Association for unspecified damages resulting from our alleged breach of
  contract and invalid termination of the International Distribution Agreement,
  originally executed between us and Sulzer Spine-Tech on July 1, 1999. On October
  9, 2001, we filed our Response to Demand for Arbitration and our counterclaims
  for breach of contract and declaratory relief. On December 3, 2001, prior to any
  arbitration hearing, we reached a negotiated settlement and mutual release with
  Sulzer Spine-Tech to dismiss the arbitration with prejudice on confidential
  terms.
  
  <PAGE>
  
                                     SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused the report to be signed on its behalf by the
  undersigned thereunto duly authorized.
  
  
                                        FUSION MEDICAL TECHNOLOGIES, INC.
  
                                        By   /S/ LARRY J. STRAUSS
                                             -------------------------------------
                                             Larry J. Strauss
  
                                             Vice President, Finance and
                                             Chief Financial Officer (Chief
                                             Accounting Officer and Duly
                                             Authorized Officer of the Registrant)
  
  Dated:  December 3, 2001
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "d8k.txt", "description": "FORM 8-K", "secsgml_size_bytes": 2894}]
metadata_filer: {"company-data": {"conformed-name": "FUSION MEDICAL TECHNOLOGIES INC", "cik": "0001013466", "assigned-sic": "3841", "irs-number": "943177221", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28460", "film-number": "1805164"}, "business-address": {"street1": "1615 PLYMOUTH STREET", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043", "phone": "4159034000"}, "mail-address": {"street1": "1615 PLYMOUTH STREET", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043"}}
text: UNITED STATES SECURITIES AND EXCHANGE COMMISSION
  
                                Washington, DC 20549
  
                                  ----------------
  
                                      FORM 8-K
                                   CURRENT REPORT
  
             Pursuant to Section 13 or 15(d) of the Securities Exchange
                             Act of 1934 Date of Report
  
                (Date of earliest event reported): December 3, 2001
  
                          Commission File Number: 000-28460
  
                          FUSION MEDICAL TECHNOLOGIES, INC.
               (Exact name of registrant as specified in its charter)
  
                Delaware                                        94-3177221
                --------                                        ----------
  (State of incorporation or organization)                (IRS Employer I.D. No.)
  
                              34715 Ardenwood Boulevard
                              -------------------------
                                  Fremont, CA 94555
                                  -----------------
                      (Address of principal executive offices)
  
                                   (510) 818-4600
                                   --------------
                (Registrant's telephone number, including area code)
  Item 5. Other Events
  
       On September 13, 2001, we received notice from Sulzer Spine-Tech Inc. that
  they had filed a Demand for Arbitration with the American Arbitration
  Association for unspecified damages resulting from our alleged breach of
  contract and invalid termination of the International Distribution Agreement,
  originally executed between us and Sulzer Spine-Tech on July 1, 1999. On October
  9, 2001, we filed our Response to Demand for Arbitration and our counterclaims
  for breach of contract and declaratory relief. On December 3, 2001, prior to any
  arbitration hearing, we reached a negotiated settlement and mutual release with
  Sulzer Spine-Tech to dismiss the arbitration with prejudice on confidential
  terms.
  SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused the report to be signed on its behalf by the
  undersigned thereunto duly authorized.
  
                                        FUSION MEDICAL TECHNOLOGIES, INC.
  
                                        By   /S/ LARRY J. STRAUSS
                                             -------------------------------------
                                             Larry J. Strauss
  
                                             Vice President, Finance and
                                             Chief Financial Officer (Chief
                                             Accounting Officer and Duly
                                             Authorized Officer of the Registrant)
  
  Dated:  December 3, 2001